DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rinaldi, R.
Right arrow Articles by Morgenstern, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rinaldi, R.
Right arrow Articles by Morgenstern, R.

Vol. 30, Issue 10, 1053-1058, October 2002

MINIREVIEW
Reactive Intermediates and The Dynamics of Glutathione Transferases

Rosanna Rinaldi, Erik Eliasson, Stellan Swedmark, and Ralf Morgenstern

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (R.R., R.M.); Karolinska Institutet, Division of Clinical Pharmacology, Huddinge University Hospital, Stockholm (E.E.); and Research Drug Metabolism and Pharmacokinetics, Astra-Zeneca R&D, Södertälje, Sweden (S.S.).

Reactive intermediates are a continuous burden in biology and several defense mechanisms have evolved. Here we focus on the functions of glutathione transferases (GSTs) with the aim to discuss the quantitative aspects of defense against reactive intermediates. Humans excrete approximately 0.1 mmol of thioether conjugates per day. As the amount of GST active sites in liver is approx 0.5 mmol, it appears that glutathione transferase catalysts are present in tremendous excess. In fact, the known catalytic properties of GSTs reveal that the enzymes can empty the liver glutathione (GSH) pool in a matter of seconds when provided with a suitable substrate. However, based on the urinary output of conjugates (or derivatives thereof), individual GSTs turn over (i.e., catalyze a single reaction) only once every few days. Glutathione transferase overcapacity reflects the fact that there is a linear relation between GST enzyme amount and protection level (provided that GSH is not depleted). Put in a different perspective, a few reactive molecules will always escape conjugation and reach cellular targets. It is therefore not surprising that signaling systems sensing reactive intermediates have evolved resulting in the increase of GSH and GST levels. Precisely for this reason, more moderately reactive electrophiles (Michael acceptors) are receiving growing interest due to their anticarcinogenic properties. Another putative regulatory mechanism involves direct activation of microsomal GST1 by thiol-reactive electrophiles through cysteine 49. The toxicological significance of low levels of reactive intermediates are of interest also in drug development, and here we discuss the use of microsomal GST1 activation as a surrogate detection marker.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
H. U. Shetty, S. S. Zoghbi, F. G. Simeon, J.-S. Liow, A. K. Brown, P. Kannan, R. B. Innis, and V. W. Pike
Radiodefluorination of 3-Fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a Radioligand for Imaging Brain Metabotropic Glutamate Subtype-5 Receptors with Positron Emission Tomography, Occurs by Glutathionylation in Rat Brain
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 727 - 735.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
J. Kool, M. Eggink, H. van Rossum, S. M. van Liempd, D. A. van Elswijk, H. Irth, J. N.M. Commandeur, J. H.N. Meerman, and N. P.E. Vermeulen
Online Biochemical Detection of Glutathione-S-Transferase P1-Specific Inhibitors in Complex Mixtures
J Biomol Screen, April 1, 2007; 12(3): 396 - 405.
[Abstract] [PDF]

Home page
 FASEB J.Home page
T. Tohami, L. Drucker, H. Shapiro, J. Radnay, and M. Lishner
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential
FASEB J, March 1, 2007; 21(3): 691 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Rius, J. Hummel-Eisenbeiss, A. F. Hofmann, and D. Keppler
Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G640 - G649.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Chen, H. G. Shertzer, S. N. Schneider, D. W. Nebert, and T. P. Dalton
Glutamate Cysteine Ligase Catalysis: DEPENDENCE ON ATP AND MODIFIER SUBUNIT FOR REGULATION OF TISSUE GLUTATHIONE LEVELS
J. Biol. Chem., October 7, 2005; 280(40): 33766 - 33774.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Gao, K. Kashfi, and B. Rigas
In Vitro Metabolism of Nitric Oxide-Donating Aspirin: The Effect of Positional Isomerism
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 989 - 997.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. M. Leslie, A. Haimeur, and M. P. Waalkes
Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1): EVIDENCE THAT A TRI-GLUTATHIONE CONJUGATE IS REQUIRED
J. Biol. Chem., July 30, 2004; 279(31): 32700 - 32708.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.